The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence

  • McKetin, Rebecca (Primary Chief Investigator (PCI))
  • Dean, Olivia (Chief Investigator (CI))
  • Lubman, Dan (Chief Investigator (CI))
  • Dietze, Paul (Chief Investigator (CI))
  • Higgs, Peter (Chief Investigator (CI))
  • Kelly, Peter (Chief Investigator (CI))
  • Turner, Alyna (Chief Investigator (CI))
  • Quinn, Brendan (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1731/12/19

Funding

  • National Health & Medical Research Council (NHMRC): AUD1,551,368.00